Hyperledger Global Forum 2021

In 2013 the Drug Supply Chain Security Act was signed into law to address the growing threat of counterfeit drugs and to ensure prescription drugs remain safe and effective. It also created new requirements for US pharmaceutical supply stakeholders, including an extended "know your customer" requirement. While larger Authorized Trading Partners (ATPs) have connectivity solutions in place, newer and smaller ATPs have not traditionally participated, including tens of thousands of dispensers. During this session, Ben Taylor will discuss the results of a peer-reviewed study that tested ATP authentication and enhanced verification in a real-world pharmacy with genuine drug packages. Participants from Genentech, Sanofi, Amgen, and UCLA Health tested enhanced verification workflows backed by Hyperledger Fabric, and were able to authenticate requests with secure verifiable credentials.